Burning Rock Biotech (BNR) Competitors $8.20 -0.29 (-3.36%) As of 03:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNR vs. TOI, LFMD, VMD, XGN, DCGO, SERA, QIPT, CORBF, EUDA, and PIIIShould you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Oncology Institute (TOI), LifeMD (LFMD), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Global Cord Blood (CORBF), EUDA Health (EUDA), and P3 Health Partners (PIII). These companies are all part of the "healthcare" industry. Burning Rock Biotech vs. Its Competitors Oncology Institute LifeMD Viemed Healthcare Exagen DocGo Sera Prognostics Quipt Home Medical Global Cord Blood EUDA Health P3 Health Partners Oncology Institute (NASDAQ:TOI) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Do analysts prefer TOI or BNR? Oncology Institute presently has a consensus price target of $7.00, suggesting a potential upside of 73.48%. Given Oncology Institute's stronger consensus rating and higher possible upside, research analysts clearly believe Oncology Institute is more favorable than Burning Rock Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.75Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Does the media favor TOI or BNR? In the previous week, Oncology Institute and Oncology Institute both had 4 articles in the media. Oncology Institute's average media sentiment score of 0.62 equaled Burning Rock Biotech'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oncology Institute 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Burning Rock Biotech 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, TOI or BNR? Oncology Institute has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500. Is TOI or BNR more profitable? Oncology Institute has a net margin of -14.26% compared to Burning Rock Biotech's net margin of -26.04%. Burning Rock Biotech's return on equity of -23.61% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Oncology Institute-14.26% -1,527.21% -34.25% Burning Rock Biotech -26.04%-23.61%-15.73% Which has preferable earnings and valuation, TOI or BNR? Burning Rock Biotech has lower revenue, but higher earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$424.38M0.89-$64.66M-$0.68-5.93Burning Rock Biotech$70.67M1.25-$47.49M-$1.90-4.32 Do institutionals & insiders hold more shares of TOI or BNR? 36.9% of Oncology Institute shares are held by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are held by institutional investors. 8.5% of Oncology Institute shares are held by company insiders. Comparatively, 30.3% of Burning Rock Biotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryOncology Institute beats Burning Rock Biotech on 8 of the 15 factors compared between the two stocks. Get Burning Rock Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNR vs. The Competition Export to ExcelMetricBurning Rock BiotechTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$88.29M$3.17B$20.45B$10.51BDividend YieldN/A1.70%2.93%4.80%P/E Ratio-4.3225.4826.6427.30Price / Sales1.2576.131,878.15197.96Price / CashN/A57.2531.1661.53Price / Book1.118.538.206.82Net Income-$47.49M$27.08M$196.57M$276.59M7 Day Performance-7.81%-0.95%-0.65%0.00%1 Month Performance-5.80%10.65%4.48%7.96%1 Year Performance183.91%69.51%53.05%35.10% Burning Rock Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNRBurning Rock Biotech0.7918 of 5 stars$8.21-3.4%N/A+171.2%$88.29M$70.67M-4.321,390News CoverageTOIOncology Institute1.8787 of 5 stars$3.81+4.7%$7.00+83.7%+1,162.7%$340.36M$393.41M-5.60660Gap UpLFMDLifeMD3.358 of 5 stars$6.94-0.4%$13.17+89.7%+36.9%$330.50M$212.45M-33.05230VMDViemed Healthcare2.2208 of 5 stars$6.87-0.9%N/A-21.0%$268.79M$224.26M20.211,179News CoverageAnalyst ForecastXGNExagen3.9455 of 5 stars$10.90-0.5%$12.00+10.1%+327.4%$241.16M$55.64M-12.25220Analyst ForecastDCGODocGo1.7886 of 5 stars$1.24-2.4%$3.24+161.1%-60.4%$124.22M$616.55M-6.534,407High Trading VolumeSERASera Prognostics1.1035 of 5 stars$3.26+0.3%N/A-56.0%$122.44M$80K-3.84120QIPTQuipt Home Medical2.6905 of 5 stars$2.57-1.5%$3.15+22.6%-13.7%$113.39M$245.91M-10.711,200CORBFGlobal Cord BloodN/A$0.75-25.0%N/A-40.2%$91.16M$196.12M0.001,200EUDAEUDA Health1.1372 of 5 stars$2.36+5.8%N/A-16.4%$82.86M$4.01M0.002News CoverageAnalyst ForecastPIIIP3 Health Partners2.8222 of 5 stars$8.91+3.0%$16.25+82.4%-43.1%$62.17M$1.50B-0.19500 Related Companies and Tools Related Companies Oncology Institute Competitors LifeMD Competitors Viemed Healthcare Competitors Exagen Competitors DocGo Competitors Sera Prognostics Competitors Quipt Home Medical Competitors Global Cord Blood Competitors EUDA Health Competitors P3 Health Partners Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNR) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
